Behçet's disease: Familial clustering and immunogenetics

Clinical and Experimental Rheumatology

Volumn 23, Issue 4 SUPPL 38, 2005, Pages

  Fietta, Pieranna ^a  

^a Parma Hospital   (Italy)

Author keywords

Beh et's disease; Familial aggregation; Familial clustering; Gene polymorphisms; Genetic anticipation; Immunogenetics; Prothrombotic mutations

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLAMINE ACETYLTRANSFERASE; CHEMOKINE RECEPTOR CCR5; CYTOCHROME P450 1A1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HLA B15 ANTIGEN; HLA B51 ANTIGEN; HLA DQ ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LYMPHOTOXIN; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR;

BEHCET DISEASE; CCL2 GENE; CCL5 GENE; CCR5 GENE; CTLA4 GENE; CYP1A1 GENE; DISEASE SEVERITY; ENOS GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; ICAM1 GENE; IL1A GENE; IL1B GENE; IL1RN GENE; IMMUNOGENETICS; MBL2 GENE; MTHFR GENE; NAT2 GENE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; REVIEW; TNFA GENE; TNFB GENE; TNFRI GENE; TNFRII GENE; TNFRSF1A GENE; TNFRSF1B GENE; GENETICS; IMMUNOLOGY; PATHOLOGY;

BEHCET SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGENETICS;

EID: 33644789835     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (181)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. GURLER A, BOYVAT A, TURSEN U: Clinical manifestations of Behçet's disease: An analysis of 2147 patients. Yonsei Med J 1997; 38: 423-7.
3. LEIBA M, SIDI Y, GUR H, LEIBA A, EHRENFELD M: Behçet's disease and thrombophilia. Ann Rheum Dis 2001; 60: 1081-5.
4. KURAL-SEYAHI EK, FRESKO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet's syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated centre. Medicine (Baltimore) 2003; 82: 60-76.
5. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
6. VERITY DH, WALLACE GR, VAUGHAN RW, STANFORD MR: Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003; 87: 1175-83.
7. GUL A: BehçeA's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S6-12.
8. TAKENO M, KARIYONE A, YAMASHITA N et al.: Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995; 38: 426-33.
9. EKSIOGLU-DEMIRALP E, DIRESKENELI H, KIBAROGLU A, YAVUZ S, ERGUN T, AKOGLU T: Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S19-24.
10. FRASSANITO MA, DAMMACCO R, CAFFORIO P, DAMMACCO F: Th1 polarization of the immune response in Behçet's disease. A putative pathogenetic role of interleukin-12. Arthritis Rheum 1999; 42: 1967-74.
11. DIRESKENELI H: BehcIcedil;et's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
12. AHMED MB, HOUMAN H, MILED M, DELLAGI K, LOUZIR H: Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 2004; 50: 2291-5.
13. MOK CC, CHEUNG TC, HO CTK, LEE KW, LAU CS, WONG RWS: Behçet's disease in southern Chinese patients. J Rheumatol 2002; 29: 1689-93.
14. AMBRESIN A, TRAN T, SPERTINI F, HERBORT C: Behçet's disease in Western Switzerland: Epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 2002; 10: 53-63.
15. POON W, VERITY DH, LARKIN GL, GRAHAM EM, STANFORD MR: Behçet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol 2003; 87: 876-8.
16. MIZUKI N, INOKO H, OHNO S: Molecular genetics (HLA) of Behçet's disease. Yonsei Med J 1997; 38: 333-49.
17. COMAS D, CALAFELL F, MATEU E et al.: Trading genes along the silk road: MtDNA sequences and the origin of central Asian populations. Am J Hum Genet 1998; 63: 1824-38.
18. ZOUBOULIS CC, KOTTER I, DJAWARI D et al.: Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
19. ZOUBOULIS CC: Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris) 1999; 150: 488-98.
20. O'NEILL T, RIGBY AS, MCHUGH S, SILMAN AJ, BARNES C: Regional differences in clinical manifestations of Behçet's disease. In WECHSLER B and GODEAU P (Eds.): Behçet's Disease: Proceedings of the 6th International Conference on Behçet's Disease. Amsterdam, Excerpta Medica 1993: 159-63.
21. DEMIROGLU H, BARISTA I, DUNDAR S: Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997; 104: 701-5.
22. KONE-PAUT I, YURDAKUL S, BAHABRI SA et al.: Clinical features of Behçet's disease in children: An international collaborative study of 86 cases. J Pediatr 1998; 132: 721-5.
23. GONZALEZ-GAY MA, GARCIA-PORRUA C, BRANAS F, LOPEZ-LAZARO L, OLIVIERI I: Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol 2000; 27: 703-7.
24. MUHAYA M, LIGTHMAN S, IKEDA E et al.: Behcet's disease in Japan and Great Britain: A comparative study. Ocul Immunol Inflamm 2000; 8: 141-8.
25. KRAUSE I, MADER R, SULKES J et al.: Behçet's disease in Israel: The influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-6.
26. KOTTER I, VONTHEIN R, MULLER CA, GUNAYDIN I, ZIERHUT M, STUBIGER N: Behçet's disease in patients of German and Turkish origin living in Germany: A comparative analysis. J Rheumatol 2004; 31: 133-9.
27. YAZICI H, TUZUN Y, PAZARLI H et al.: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984; 43: 783-9.
28. TURSEN U, GURLER A, BOYVAT A: Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003; 42: 346-5 l.
29. TUGAL-TUTKUN I, ONAL S, ALTAN-YAYCIOGLU R, HUSEYIN ALTUNBAS H, URGANCIOGLU M: Uveitis in BehcAcedil;et's disease: an analysis of 880 patients. Am J Ophthalmol 2004; 138: 373-80.
30. TOYDEMIR PB, ELHAN AH, TUKUN A et al.: Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. J Rheumatol 2000; 27: 2849-54.
31. AMES PRJ, STEUER A, PAP A, DENMAN AM: Thrombosis in Behçet's disease: A retrospective survey from a single UK centre. Rheumatology (Oxford) 2001; 40: 652-5.
32. MIZUKI N, OTA M, YABUKI K et al.: Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000; 41: 3702-8.
33. MIZUKI N, YABUKI K, OTA M et al.: Microsatellite mapping of a susceptible locus within the HLA region for Behçet's disease using Jordanian patients. Hum Immunol 2001; 62: 186-90.
34. YAZICI H, TUZUN Y, PAZARLI H, YALCIN B, YURDAKUL S, MUFTUOGLU A: The combined use of HLA-B5 and the pathergy test as diagnostic marker of Behçet's disease in Turkey. J Rheumatol 1980; 7: 206-10.
35. NISHIYAMA M, NAKAE K, KURIYAMA T, HASHIMOTO M, HSU ZN: A study among related pairs of Japanese patients with familial Behçet's disease: group comparison by interval of disease onsets. J Rheumatol 2002; 29: 743-7.
36. HAMURYUDAN V, YURDAKUL S, OZBAKIR F, YAZICI H, HEKIM H: Monozygotic twins concordant for Behçet's syndrome. Arthritis Rheum 1991; 34: 1071-2.
37. YAZGANOGLU KD, POLAT EA, AKDAG KOSE A, DILER S, AZIZLERLI G: HLA-B51 positive monozygotic twins concordant for Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S90.
38. BERMAN L, TRAPPLER BA JENKINS T: Behçet's syndrome: a family study and the elucidation of a genetic role. Ann Rheum Dis 1979; 38: 118-21.
39. BIRD STEWART JA: Genetic analysis of families of patients with Behçet's syndrome: Data incompatible with autosomal recessive inheritance. Ann Rheum Dis 1986; 45: 265-8.
40. MOLINARI N, KONE-PAUT I, MANNA R, DEMAILLE J, DAURES JP, TOUITOU I: Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet 2003; 122A: 115-8.
41. FRESKO I, SOY M, HAMURYUDAN et al.: Genetic anticipation in Behçet's syndrome. Ann Rheum Dis 1998; 57: 45-8.
42. SONMEZ S, KAYA M, AKTAS A, IKBAL M, SENEL K: High frequency of sister chromatid exchanges in lymphocytes of the patients with Behçet's disease. Mutat Res 1998; 397: 235-8.
43. SEZER NF: Further investigation of the virus of Behçet's disease. Am J Ophthalmol 1956; 41: 41-55.
44. FORBES IJ, ROBSON HN: Familial recurrent orogenital ulceration. Br Med J 1960; 5173: 599-601.
45. FOWLER TJ, HUMPSTON DJ, NUSSEY AM, SMALL M: Behçet's syndrome with neurological manifestations in two sisters. Br Med J 1968; 2: 473-4.
46. MASON RM, BARNES CG: Behçet's syndrome with arthritis. Ann Rheum Dis 1969; 28: 95-103.
47. KORCZYN AD, BORNSTEIN B: Familial Behçet disease. Harefuah 1973; 84: 130-2.
48. CHAJEK T, FAINARU M: Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975; 54: 179-96.
49. GOOLAMALI SK, COMAISH JS, HASSANYEK F, STEPHENS A: Familial Behçet's syndrome. Br J Dermatol 1976; 95: 637-42.
50. ABDEL-AZIZ AH, FAIRBURN EA: Familial Behçet's syndrome. Cutis 1978; 21: 649-52.
51. NAHIR M, SCHARF Y, GIDONI O, BRAZILAI A, FRIEDMAN-BIRNBAUM R, HAIM S: HLA antigens in Behçet's disease. A family study. Dermatologica 1978; 156: 205-8.
52. AOKI K, OHNO S, OHGUSHI M, SUGIURA S: Familial Behçet's disease. Jpn J Ophthalmol 1978; 22: 72-5.
53. ARONSSON A, TEGNER E: Behçet's syndrome in two brothers. Acta Derm Venereol 1983; 63: 73-4.
54. GONZALEZ T, GANTES M, BUSTABAD S: HLA haplotypes in familial Behçet's disease. J Rheumatol 1984; 11: 405-6.
55. DUNDAR SV, GENCALP U, SIMSEK H: Familial cases of Behçet's disease. Br J Dermatol 1985; 113: 319-21.
56. YIM CW, WHITE RH: Behçet's syndrome in a family with inflammatory bowel disease. Arch Intern Med 1985; 145: 1047-50.
57. FALLINGBORG J, AMBROSIUS CHRISTENSEN L, GRUNNET N: HLA antigens in a family with Behçet's syndrome. Acta Med Scand 1986; 220: 375-8.
58. WILKINS MR, GOVE RI, ROBERTS SD, KENDALL MJ: Behçet's disease presenting as benign intracranial hypertension. Postgrad Med J 1986; 62: 39-41.
59. GRUFFERMAN S, BARTON JW 3RD, EBY NL: Increased sex concordance of sibling pairs with Behçet's disease, Hodgkin's disease, multiple sclerosis, and sarcoidosis. Am J Epidemiol 1987; 126: 365-9.
60. WOODROW JC, GRAHAM DR, EVANS CC: Behçet's syndrome in HLA-identical siblings. Br J Rheumatol 1990; 29: 225-7.
61. AKPOLAT T, KOC Y, YENIAY I et al.: Familial Behçet's disease. Eur J Med 1992; 1: 391-5.
62. KONE I, BERBIS P, PALIX C, BERNARD JL: Familial Behçet's disease in children. A report of 3 cases. Clin Exp Rheumatol 1992; 10: 627-8.
63. VILLANUEVA JL, GONZALEZ-DOMINGUEZ J, GONZALEZ FERNANDEZ R, PRADA JL, PENA J, SOLANA R: HLA antigen familial study in complete Behçet's syndrome affecting three sisters. Ann Rheum Dis 1993; 52: 155-7.
64. CHONG VF, PATHMANATHAN R: Familial Behçet's syndrome with intestinal involvement-case reports and a review of the literature. Ann Acad Med Singapore 1993; 22: 807-10.
65. KONE-PAUT I, BERNARD JL: Behçet's disease in children in France. Arch Fr Pediatr 1993; 50: 561-5.
66. HAYASAKA S, KUROME H, NODA S: HLA antigens in a Japanese family with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 1994; 232: 589-90.
67. MORI M, KURIYAMA T, MITSUDA T et al.: Familial Behçet's disease-a case report. Ryumachi 1994; 34: 988-92.
68. VAIOPOULOS G, SFIKAKIS PP, HATZINIKO-LAOU P, STAMATELOS G, KAKLAMANIS P: Adamantiadis-Behçet's disease in sisters. Clin Rheumatol 1996; 15: 382-4.
69. NISHIURA K, KOTAKE S, ICHIISHI A, MATSUDA H: Familial occurrence of Behçet's disease. Jpn J Ophthalmol 1996; 40: 255-9.
70. ANDO H, MIZUKI N, OHNO S et al.: Identification of a novel HLA-B allele (B*4202) in a Saudi Arabian family with Behçet's disease. Tissue Antigens 1997; 49: 526-8.
71. BANG D, YOON KH, CHUNG HG, CHOI EH, LEE ES, LEE S: Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J 1997; 38: 428-36.
72. MACGREGOR AJ, SEAMAN G, DENMAN E, DENMAN AM: Disease recurrence risk and the risk of lymphoproliferative disorders in the relatives of patients with Behçet's syndrome: Results of a nationwide survey. Br J Rheumatol 1997; 36 (Suppl. 1): 34.
73. SANT SM, KILMARTIN D, ACHESON RA: HLA antigens in familial Behçet's disease in Ireland. Br J Rheumatol 1998; 37: 1250-57.
74. KONE-PAUT I, GEISLER I, WECHSLER B et al.: Familial aggregation in Behçet's disease: High frequency in siblings and parents of paediatric probands. J Pediatr 1999; 135: 89-93.
75. TREUDLER R, ORFANOS CE, ZOUBOULIS CC: Twenty-eight cases of juvenile-onset Adamantiades-Behçet's disease in Germany. Dermatology 1999; 199: 15-9.
76. GUL A, INANC M, OCAL L, ARAL O, KONICE M: Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000; 59: 622-5.
77. ONAL S, TUGAL-TUTKUN I, URGANCIOGLU M, GUL A: Clinical course of ocular Behçet's disease in siblings. Ocul Immunol Inflamm 2001; 9: III-24.
78. NISHYIAMA M, NAKAE K, UMEHARA T: A study of familial occurrence of Behçet's disease with and without ocular lesions. Jpn J Ophthalmol 2001; 45: 313-6.
79. GUL A, UYAR FA, INANC M et al.: Lack of association of HLA-B*51 with a severe disease course in Behçet's disease. Rheumatology (Oxford) 2001; 40: 668-72.
80. GUL A, HAJEER AH, WORTHINGTON J, BARRETT JH, OLLIER WER, SILMAN AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44: 239-40.
81. LAGHMARI M, KARIM A, ALLALI F et al.: Childhood Behçet's disease: Clinical and evolutive aspects. About 13 cases. J Fr Ophthalmol 2002; 25: 904-8.
82. AL-JOOFY IK, MUSLIH RK, MOUSAWY KM, AL-WAIZ MM: HLA typing class I and II antigens in Iraqi patients with Behçet's disease (sporadic and familial cases). Adv Exp Med Biol 2003; 528: 217-20.
83. ZOUBOULIS CC, VAIOPOULOS G, MARCOMICHELAKIS N et al.: Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S19-26.
84. ALLALI F, BENOMAR A, KARIM A et al.: Behçet's disease in Moroccan children: A report of 12 cases. Scand J Rheumatol 2004; 33: 362-3.
85. GUL A, INANC M, OCAL L, ARAL O, CARIN M, KONICE M: HLA-B51 negative monozygotic twins discordant for Behçet's disease. Br J Rheumatol 1997; 36: 922-7.
86. KILMARTIN DJ, FINCH A, ACHESON RW: Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 1997; 81: 649-53.
87. KRAUSE I, LEIBOVICI L, GUEDJ D, MOLAD Y, UZIEL Y, WEINBERGER A: Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 1999; 17: 347-50.
88. KAYA TI, DUR H, TURSEN U, GURLER A: Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease. Clin Exp Dermatol 2002; 27: 498-501.
89. CASTILLO PALMA MJ, SANCHEZ ROMAN J, OCANA MEDINA C, GONZALEZ ESCRIBANO MF, NUNEZ ROLDAN A, LOPEZCHECA F: Serologic and molecular HLA typing in patients from Andalucia with Behçet's disease. Genetic and clinical correlations. Med Clin (Barc) 1996; 106: 121-5.
90. CHOUKRI F, CHAKIB A, HIMMICH H, MARIH L, CAILLAT-ZUCMAN S: HLA-B phenotype modifies the course of Behçet's disease in Moroccan patients. Tissue Antigens 2003; 61: 92-6.
91. CHANG HK, KIM JU, CHEON KS, CHUNG HR, LEE KW, LEE IH: HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; (Suppl. 24): S31-5.
92. ERMAKOVA NA, ALEKBEROVA ZS, PROKAEVA TB, POLJANSKAJA IB: Frequency of HLA in patients with Behçet's disease and association with occlusive retinal vasculitis. Adv Exp Med Biol 2003; 528: 231-3.
93. SANO K, YABUKI K, IMAGAWA Y et al.: The absence of disease-specific polymorphisms within the HLA-B51 that is the susceptible locus for Behçet's disease. Tissue Antigens 2001; 58: 77-82.
94. GONZALEZ-ESCRIBANO MF, RODRIGUEZ MR, WALTER K, SANCHEZ-ROMAN J, GARCIA-LOZANO JR, NUNEZ-ROLDAN A: Association of HLA-B51 subtypes and Behçet's disease in Spain. Tissue Antigens 1998; 52: 78-80.
95. KERA J, MIZUKI N, OTA M et al.: Significant associations of HLA-B*5101 and B*5108, and lack of associations of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 1999; 54: 565-71.
96. MIZUKI N, OTA M, KATSUYAMA Y et al.: Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and B*5108 with Behçet's disease in Greek patients. Tissue Antigens 2002; 59: 118-21.
97. KOTTER I, GUNAYDIN I, STUBIGER N et al.: Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens 2001; 58: 166-70.
98. MIZUKI N, OTA M, KATSUYAMA Y et al.: HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet's disease. Tissue Antigens 2001; 57: 457-62.
99. YABUKI K, OHNO S, MIZUKI N et al.: HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. Tissue Antigens 1999; 54: 273-7.
100. MIZUKI N, OTA M, KATSUYAMA Y et al.: HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease. Tissue Antigens 2001; 58: 181-4.
101. KOUMANTAKI Y, STAVROPOULOS C, SPYROPOULOU M et al.: HLA-B*5101 in Greek patients with Behçet's disease. Hum Immunol 1998; 59: 250-5.
102. ARBER N, KLEIN T, MEINER Z, PRAS E, WEINBERGER A: Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis 1991; 50: 351-3.
103. PAUL M, KLEIN T, KRAUSE I, MOLAD Y, NARINSKY R, WEINBERGER A: Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease. Tissue Antigens 2001; 58: 185-6.
104. XU L, YU L, FAN L: Study on association of HLA-B*51 alleles with Behçet's disease in Chinese Han population in Shanghai area. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S89.
105. TAKEMOTO Y, NARUSE T, ITO N et al.: Comparison of HLA-B51 haplotypes and microsatellite polymorphisms in Behçet's disease among multiple populations. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S89.
106. GUL A, UYAR FA, INANC M et al.: A weak association of HLA-B*2702 with Behçet's disease. Genes Immun 2002; 3: 368-72.
107. CHOUKRI F, CHAKIB A, HIMMICH H, HUE S, CAILLAT-ZUCMAN S: HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients. Hum Immunol 2001; 62: 180-5.
108. AHMAD T, WALLACE GR, JAMES T et al.: Mapping the HLA association in Behçet's disease. A role for tumour necrosis factor polymorphisms? Arthritis Rheum 2003; 48: 807-13.
109. CHOI JS, NAM JH, BANG D, LEE ES, LEE S, PARK KS: HLA-G 3741 14bp insertion in the 3′-UTR in Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S91.
110. MATSUKI K, JUJI T, TOKUNAGA K et al.: HLA antigens in Behçet's disease with refractory ocular attacks. Tissue Antigens 1987; 29: 208-13.
111. MINESHITA S, TIAN D, WANG LM et al.: Histocompatibility antigens associated with Behçet's disease in northern Han Chinese. Intern Med 1992; 31: 1073-5.
112. BALBONI A, PIVETTI-PEZZI P, ORLANDO P et al.: Serological and molecular HLA typing in Italian Behçet's patients: Significant association to B51-DR5-DQw3 haplotype. Tissue Antigens 1992; 39: 141-3.
113. ALPSOY E, YILMAZ E, COSKUN M, SAVAS A, YEGIN O: HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients. J Dermatol 1998; 25: 158-62.
114. SUN A, HSIEH RP, CHU CT, WANG JT, LIU BY, CHIANG CP: Some specific human leukocyte antigen (HLA)-DR/DQ haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease. J Oral Pathol Med 2001; 30: 402-7.
115. SOTO-VEGA E, GARCIA-MUNOZ R, RICHAUD-PATIN Y et al.: Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. Immunol Lett 2004; 93: 211-5.
116. MIZUKI N, OHNO S, ANDO H et al.: HLA-C genotyping of patient with Behçet's disease in the Japanese population. Hum Immunol 1996; 15: 47-53.
117. SANZ L, GONZALEZ-ESCRIBANO F, DE PABLO R, NUNEZ-ROLDAN A, KREISLER M, VILCHES C: HLA-Cw*1602: a new susceptibility marker of Behçet's disease in southern Spain. Tissue Antigens 1998; 51: 111-4.
118. DUYMAZ-TOZKIR J, GUL A, UYAR FA, OZBEK U, SARUHAN-DIRESKENELI G: Tumour necrosis factor-alpha gene promoter region -308 and -376 G→A polymorphisms in Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S15-8.
119. VERITY DH, WALLACE GR, VAUGHAN RW et al.: HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens 1999; 54: 264-72.
120. LEE EB, KIM JY, LEE YJ, PARK MH, SONG YW: TNF and TNF receptor polymorphisms in Korean Behçet's disease patients. Hum Immunol 2003; 64: 614-20.
121. AMOURA Z, DODE C, HUE S et al.: Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis Rheum 2005; 52: 608-11.
122. MIZUKI N, OTA M, KIMURA M et al.: Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci USA 1997; 94: 1298-303.
123. PARK SH, PARK KS, SEO YI et al.: Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behçet's disease. J Korean Med Sci 2002; 17: 366-70.
124. MOK J, BANG D, LEE ES, LEE S, PARK KS; Strong association of MIC-A*009 of extracellular domains and MIC-A*A6 of transmembrane domain in Korean patients with Behçet's disease. Adv Exp Med Biol 2003; 528: 221-4.
125. MIZUKI N, YABUKI K, OTA M et al.: Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 2002; 60: 396-9.
126. YABUKI K, MIZUKI N, OTA M et al.: Association with MICA gene and HLA-B*5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci 1999; 40: 1921-6.
127. WALLACE GR, VERITY DH, DELAMAINE LJ et al.: MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics 1999; 49: 613-7.
128. COHEN R, METZGER S, NAHIR M, CHAJEKSHAUL T: Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 2002; 61: 157-60.
129. GONZALEZ-ESCRIBANO MF, RODRIGUEZ MR, AGUILAR F, ALVAREZ A, SANCHEZ-ROMAN J, NUNEZ-ROLDAN A: Lack of association of MICA transmembrane region polymorphism and Behçet's disease in Spain. Tissue Antigens 1999; 54: 278-81.
130. BEN AHMED M, HOUMAN H, ABDELHAK S et al.: MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients. Adv Exp Med Biol 2003; 528: 225-8.
131. PICCO P, PORFIRIO B, GATTORNO M et al.: MICA gene polymorphisms in an Italian paediatric series of juvenile Behçet disease. Int J Mol Med 2002; 10: 575-8.
132. MIZUKI N, OTA M, KATSUYAMA Y et al.: Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum 1999; 42: 1961-6.
133. SALVARANI C, BOIARDI L, MANTOVANI V et al.: Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease. J Rheumatol 2001; 28: 1867-70.
134. YASUOKA H, OKAZAKI Y, KAWAKAMI Y et al.: Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 2004; 50: 3658-62.
135. GONZALEZ-ESCRIBANO MF, MORALES J, GARCIA-LOZANO JR et al.: TAP polymorphism in patients with Behçet's disease. Ann Rheum Dis 1995; 54: 386-8.
136. TAKIZAWA K, TAKEUCHI F, NABETA H et al.: Association of transporter associated with antigen processing genes with Behçet's disease in Japanese. Autoimmunity 2003; 36: 161-5.
137. BOIARDI L, SALVARANI C, CASALI B et al.: Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. J Rheumatol 2001; 28: 1283-7.
138. VERITY DH, VAUGHAN RW, KONDEATIS E et al.: Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet 2000; 27: 73-6.
139. KIM EH, MOK JW, BANG DS, LEE ES, LEE SN, PARK KS: Intercellular adhesion molecule-I gene polymorphisms in Korean patients with Behçet's disease. J Korean Med Sci 2003; 18: 415-8.
140. KARASNEH J, HAJEER AH, BARRETT J, OLLIER WE, THORNHILL M, GUL A: Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet's disease. Rheumatology (Oxford) 2003; 42: 860-4.
141. COSKUN M, BACANLI A, SALLAKCI N, ALPSOY E, YAVUZER U, YEGIN O: Specific interleukin-1 gene polymorphisms in Turkish patients with Behçet's disease. Exp Dermatol 2005; 14: 124-9.
142. BICAKCIGIL M, YILMAZ V, DIRESKENELI H, SARUHAN-DIRESKENELI G: Cytokine polymorphisms associated with Behçet's disease in Turkey. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S91.
143. CHANG HK, JANG WC, PARK SB et al.: Association between interleukin 6 gene polymorphisms and Behçet's disease in Korean people. Ann Rheum Dis 2005; 64: 339-40.
144. BOIARDI L, SALVARANI C, CASALI B et al.: Single-nucleotide polymorphism located at position 607 of the interleukin-18 gene promoter region in Behçet's disease. Arthritis Rheum 2004; 50 (Suppl. 9): S232.
145. CHEN Y, VAUGHAN RW, KONDEATIS E et al.: Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 2004; 63: 41-5.
146. YANG X, AHMAD T, GOGUS F et al.: Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease. Eur J Immunogenet 2004; 31: 11-4.
147. CHO ML, KIM JY, KO HJ et al.: The MCP-1 promoter -2518 polymorphism in Behçet's disease: Correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 2004; 37: 77-80.
148. PARK KS, MIN K, NAM JH, BANG D, LEE ES, LEE S: HYPA haplotype in the mannose binding lectin gene (MBL2) is associated with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S90.
149. WANG H, NAKAMURA K, INOUE T et al.: Mannose-binding lectin polymorphisms in patients with Behçet's disease. J Dermatol Sci 2004; 36: 115-7.
150. TAMER L, TURSEN U, ESKANDARI G et al.: N-acetyltransferase 2 polymorphisms in patients with Behçet's disease. Clin Exp Dermatol 2005; 30: 56-60.
151. AYNACIOGLU AS, BOZKURT A, NACAK M et al.: N-acetyltransferase polymorphism in patients with Behçet's disease. Eur J Clin Pharmacol 2001; 57: 659-62.
152. SALVARANI C, BOIARDI L, CASALI B et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 2002; 29: 535-40.
153. KIM JU, CHANG HK, LEE SS et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 2003; 62: 1083-7.
154. OKSEL F, OZMEN M, AKSU K, KESER G, BERDELI A: Endothelial nitric oxide synthase gene polymorphisms in Turkish patients with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S92.
155. TURSEN U, TAMER L, ESKANDARI G et al.: Glutathione S-tranferase polymorphisms in patients with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S90.
156. YEN JH, TSAI WC, LIN CH, OU TT, HU CJ, LIU HW: Cytochrome p450 1A1 and manganese superoxide dismutase gene polymorphisms in Behçet's disease. J Rheumatol 2004; 31: 736-40.
157. OZBALKAN Z, ERTENLI I, KIRAZ S et al.: Heat shock protein (HSP) 60/65 gene polymorphism in Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S92.
158. AKSU K, BERDELI A, KESER G et al.: Fcγ - RIIa, IIIa and IIIb receptor gene polymorphism in Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S92.
159. ERKEN E, GUNESACAR R, OZER HTE: C5a receptor polymorphism in Behçet's disease. Negative association with uveitis. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S91.
160. DUYMAZ-TOZKIR J, DUYAR FA, SARUHAN-DIRESKENELI G, GUL A: Killer immunoglobulin-like receptor gene 3DL1/3DS1 polymorphism in Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S91.
161. XU L, FAN L, YU L: Association of killer immunoglobulin-like receptor (KIR) gene polymorphism with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S91.
162. SALLAKCI N, BACANLI A, COSKUN M, YAVUZER U, YEGIN O, ALPSOY E: CTLA-4 gene polymorphism in Turkish patients with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S92.
163. GUNESACAR R, ERKEN E, OZER HTE: Analysis of CTLA-4 and C28 gene polymorphisms in patients with Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S92.
164. SALVARANI C, BOIARDI L, CASALI B et al.: Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol 2004; 31: 1785-9.
165. CANATAROGLU A, TANRIVERDI K, INAL T et al.: Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine levels in Behçet's disease. Rheumatol Int 2003; 23: 236-40.
166. LEIBA M, SELIGSOHN U, SIDI Y et al.: Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004; 63: 1445-9.
167. GUL A, OZBEK U, OZTURK C, INANC M, KONICE M, OZCELIK T: Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 1996; 35: 1178-80.
168. MAMMO L, AL-DALAAN A, BAHABRI SS, SAOUR JN: Association of factor V Leiden with Behçet's disease. J Rheumatol 1997; 24: 2196-8.
169. ONER AF, GURGEY A, GURLER A, MESCI L: Factor V Leiden mutation in patients with Behçet's disease. J Rheumatol 1998; 25: 496-8.
170. GURGEY A, BALTA G, BOYVAT A: Factor V Leiden mutation and PAI-1 gene 4G/ 5G genotype in thrombotic patients with Behçet's disease. Blood Coagul Fibrinolysis 2003; 14: 121-4.
171. LESPRIT P, WECHSLER B, PIETTE JC et al.: Activated protein C resistance caused by factor V Arg 506→G1n mutation has no role in thrombotic manifestations of Behçet's disease. Ann Rheum Dis 1995; 54: 860.
172. ESPINOSA G, FONT J, TASSIES D et al.: Vascular involvement in Behçet's disease: Relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 2002; 112: 37-43.
173. ATES A, DUZGUN N, ULU A, TIRYAKI AO, AKAR N: Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease. Pathophysiol Haemost Thromb 2003; 33: 157-63.
174. SILINGARDI M, SALVARANI C, BOIARDI L et al.: Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Care Res 2004; 51: 177-83.
175. VERITY DH, VAUGHAN RW, MADANAT W et al.: Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol 1999; 128: 352-6.
176. BATIOGLU F, ATMACA LS, KARABULUT HG, BEYZA SAYIN D: Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease. Acta Ophthalmol Scand 2003; 81: 283-5.
177. CHEN Y, STANFORD MR, WALLACE GR, VAUGHAN RW, KONDEATIS E, FORTUNE F: Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease. Br J Ophthalmol 2003; 87: 1048-9.
178. GUL A, ASLANTAS AB, TEKINAY T, KONICE M, OZCELIK T: Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology (Oxford) 1999; 38: 1298-99.
179. SALVARANI C, CALAMIA K, SILINGARDI M, GHIRARDUZZI A, OLIVIERI I. Thrombosis associated with the prothrombin gene G→A 20210 mutation in Behçet's disease. J Rheumatol 2000; 27: 515-6.
180. VAYA A, FORNER MJ, ESTELLES A et al.: Intracardiac thrombosis in a case of Behçet's disease associated with the prothrombin 20210G-A mutation. Haematologica 2000; 85: 425-8.
181. POLAT G, ESKANDARI G, KAYA TI et al.: Association of the platelet glycoprotein Ia C807T/G873A gene polymorphism and thrombosis in Behçet patients. Haematologia (Budap) 2002; 32: 121-8.